DDrare: Database of Drug Development for Rare Diseases

Human embryonic stem cell derived retinal pigment epithelium (rpe) (DrugBank: -)

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03963154 (ClinicalTrials.gov)	August 19, 2019	22/5/2019	Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation	STREAM: A Phase 1/2, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Implantation Into One Eye of hESC-derived RPE in Patients With Retinitis Pigmentosa Due to Monogenic Mutation	Retinitis Pigmentosa	Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)	Centre d'Etude des Cellules Souches	NULL	Recruiting	18 Years	65 Years	All	12	Phase 1;Phase 2	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03963154
(ClinicalTrials.gov)

August 19, 2019

22/5/2019

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

STREAM: A Phase 1/2, Open-label, Safety, Tolerability and Preliminary Efficacy Study of Implantation Into One Eye of hESC-derived RPE in Patients With Retinitis Pigmentosa Due to Monogenic Mutation

Retinitis Pigmentosa

Biological: Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)

Centre d'Etude des Cellules Souches

NULL

Recruiting

18 Years

65 Years

All

Phase 1;Phase 2

France